Navigation Links
Thoratec Schedules Fiscal 2008 Year-End Conference Call, Webcast
Date:1/29/2009

PLEASANTON, Calif., Jan. 29 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the fiscal 2008 year on Thursday, February 5.

The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 1:30 p.m., Pacific Standard Time (4:30 p.m., Eastern Standard Time), Thursday, February 5, hosted by Gary F. Burbach, president and chief executive officer, and David V. Smith, executive vice president and chief financial officer.

    The teleconference can be accessed by calling (719) 325-2390, passcode
7541788. Please dial in 10-15 minutes prior to the beginning of the call.
The webcast will be available on the Internet at
http://phx.corporate-ir.net/phoenix.zhtml?p=irol-
eventDetails&c=95989&eventID=2073636 or athttp://www.thoratec.com.

A replay of the conference call will be available through Thursday, February 12, via http://www.thoratec.com or by telephone at (719) 457-0820, passcode 7541788.

Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with nearly 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) division supplies point-of-care blood testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's web sites at http://www.thoratec.com or http://www.itcmed.com.


'/>"/>
SOURCE Thoratec Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Thoratec Presentation at Piper Jaffary Conference to be Webcast
2. Thoratec Reports 44 Percent Increase in Second Quarter Revenues;
3. Thoratec Schedules Second Quarter 2008 Conference Call, Webcast
4. Thoratec Schedules First Quarter 2008 Conference Call, Webcast
5. Thoratec Announces Unanimous FDA Advisory Panel Recommendation for Approval of HeartMate II(R) for Bridge-to-Transplantation
6. URGENT Thoratec Corporation Worldwide Recall of Implantable Ventricular Assist Device
7. Thoratecs ITC Division Receives FDA Warning Letter
8. Thoratec Schedules Third Quarter Conference Call, Webcast
9. Gentiva(R) Health Services Schedules Fourth Quarter and Fiscal 2008 Earnings Call and Web Cast for Wednesday, February 18, 2009
10. Triple-S Management Corporation Schedules Fourth-Quarter and Year-End Earnings Release and Webcast
11. The Advisory Board Company Schedules Third Quarter Investor Conference Call for February 9, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... 2017 , ... An intensive search of the medical literature has revealed no ... PhD. He says investigating this possibility, is important because Miami-Dade in 2016 ... infections with HIV. , His findings appear on Analizir.com. . Dr. ...
(Date:3/22/2017)... Providence, RI (PRWEB) , ... March 22, 2017 ... ... Dr. Gwynne Bragdon to its Department of Orthopedic Surgery, Division of Hand, Upper ... extremity and orthopedic surgery. She is board-certified in both Orthopedics and Hand ...
(Date:3/22/2017)... Milford, PA (PRWEB) , ... March 22, 2017 , ... ... producers, according to a US Department of Agriculture report. While excess dairy can ... sensitivity play a role. Lactose sensitivity is the inability to properly digest lactose, a ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... communities throughout north Jersey and the New York metropolitan region, is embarking on ... support for homeless families. , At present, more than two and a half ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Vanderbeck Agency, a ... greater Nassau County region, is embarking on a combined charity effort with the Great ... For the last 25 years, the Great Neck Breast Cancer Coalition has worked to ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... 2017   Upsher-Smith Laboratories, Inc . (Upsher-Smith) today announced ... 50 mg and 75 mg, the generic equivalent to Mallinckrodt ... The clomipramine hydrochloride capsules market had U.S. sales of ... according to IMS Health. ... "Upsher-Smith has long been recognized within the ...
(Date:3/22/2017)... , March 22, 2017  As the world,s leading ... Lymphoma Society (LLS) has played a role in most ... of which are even helping patients with other cancers ... LLS,s significant investment in cutting-edge research – more than ... to grow with the record-breaking sum of $4.1 million ...
(Date:3/22/2017)... N.C. , March 22, 2017  Levine ... computed tomography (CT) unit designed to address lung ... populations across the Carolinas. The mobile lung unit ... lung cancer education and treatment interventions through integrated ... Financial barriers and a lack ...
Breaking Medicine Technology: